These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33116820)

  • 1. MCM10 Acts as a Potential Prognostic Biomarker and Promotes Cell Proliferation in Hepatocellular Carcinoma: Integrated Bioinformatics Analysis and Experimental Validation.
    Wan W; Shen Y; Li Q
    Cancer Manag Res; 2020; 12():9609-9619. PubMed ID: 33116820
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Cheng C; Wu X; Shen Y; Li Q
    Cancer Manag Res; 2020; 12():13241-13257. PubMed ID: 33380832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying potential prognosis markers in hepatocellular carcinoma
    Hu X; Zhou J; Zhang Y; Zeng Y; Jie G; Wang S; Yang A; Zhang M
    Front Genet; 2022; 13():942454. PubMed ID: 35928445
    [No Abstract]   [Full Text] [Related]  

  • 6. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression.
    Liu Z; Li J; Chen J; Shan Q; Dai H; Xie H; Zhou L; Xu X; Zheng S
    BMC Cancer; 2018 Feb; 18(1):200. PubMed ID: 29463213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
    Wang Q; Yu X; Zheng Z; Chen F; Yang N; Zhou Y
    PeerJ; 2021; 9():e11342. PubMed ID: 33987018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.
    Xue H; Sun Z; Wu W; Du D; Liao S
    Cancer Manag Res; 2021; 13():117-131. PubMed ID: 33447084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 12. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
    Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
    Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 14. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular Carcinoma.
    Liao X; Liu X; Yang C; Wang X; Yu T; Han C; Huang K; Zhu G; Su H; Qin W; Huang R; Yu L; Deng J; Zeng X; Ye X; Peng T
    J Cancer; 2018; 9(13):2357-2373. PubMed ID: 30026832
    [No Abstract]   [Full Text] [Related]  

  • 16. Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCC.
    Wu C; Qi X; Qiu Z; Deng G; Zhong L
    Aging (Albany NY); 2021 Sep; 13(18):22148-22163. PubMed ID: 34491228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis of the prognostic biomarkers and predictive accuracy of differentially expressed genes in high-risk multiple myeloma based on Gene Expression Omnibus database mining.
    Du C; Guo D; Zhang Y; Gao C; Bai J
    Ann Transl Med; 2022 Dec; 10(24):1325. PubMed ID: 36660705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
    Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
    Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of MCM family as potential therapeutic and prognostic targets for hepatocellular carcinoma based on bioinformatics and experiments.
    Lei Y; Wang S; Liu J; Yan W; Han P; Tian D
    Life Sci; 2021 May; 272():119227. PubMed ID: 33607151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis.
    Xie S; Jiang X; Zhang J; Xie S; Hua Y; Wang R; Yang Y
    PeerJ; 2019; 7():e7408. PubMed ID: 31392101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.